OPRX

OptimizeRx Corp

Oct 13 • 04:00PM ET

18.73

+0.65 3.60 %

Healthcare • Health Information Services • USA • NASD

Peers: TDOC VEEV HSTM GDRX PEGA OTLK HIMX HUT DHX

| Held by: VTI IWM DWAS VXF IWO VTWO JSML VFMO DFAS DFAT

Index	RUT	P/E	-	EPS (ttm)	-0.54	Insider Own	9.78%	Shs Outstand	18.56M	Perf Week	5.94%
Market Cap	347.72M	Forward P/E	24.24	EPS next Y	0.77	Insider Trans	-0.70%	Shs Float	16.75M	Perf Month	8.08%
Enterprise Value	360.11M	PEG	-	EPS next Q	0.05	Inst Own	72.25%	Short Float	10.24%	Perf Quarter	44.41%
Income	-9.87M	P/S	3.32	EPS this Y	97.04%	Inst Trans	5.87%	Short Ratio	4.79	Perf Half Y	130.38%
Sales	104.75M	P/B	2.91	EPS next Y	18.85%	ROA	-5.77%	Short Interest	1.72M	Perf YTD	285.39%
Book/sh	6.43	P/C	20.96	EPS next 5Y	50.28%	ROE	-8.21%	52W High	20.69 -9.50%	Perf Year	193.11%
Cash/sh	0.89	P/FCF	32.83	EPS past 3/5Y	- -36.18%	ROIC	-6.82%	52W Low	3.78 395.50%	Perf 3Y	22.34%
Dividend Est.	-	EV/EBITDA	45.07	Sales past 3/5Y	14.55% 30.23%	Gross Margin	60.23%	Volatility	5.34% 6.18%	Perf 5Y	-12.35%
Dividend TTM	-	EV/Sales	3.44	EPS Y/Y TTM	46.13%	Oper. Margin	3.47%	ATR (14)	1.14	Perf 10Y	530.64%
Dividend Ex-Date	-	Quick Ratio	2.57	Sales Y/Y TTM	25.90%	Profit Margin	-9.42%	RSI (14)	53.33	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	2.57	EPS Q/Q	136.72%	SMA20	0.70%	Beta	1.26	Target Price	19.50
Payout	-	Debt/Eq	0.24	Sales Q/Q	55.19%	SMA50	7.18%	Rel Volume	0.62	Prev Close	18.08
Employees	129	LT Debt/Eq	0.21	Earnings	Aug 07 AMC	SMA200	66.50%	Avg Volume	358.47K	Price	18.73
IPO	May 18, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	1337.13% 31.15%	Trades		Volume	225,433	Change	3.60%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$7 → $6
Dec-20-24	Initiated	Stephens	Equal-Weight	$5.50
Jul-25-24	Resumed	B. Riley Securities	Buy	$18.50
Apr-04-24	Initiated	JMP Securities	Mkt Outperform	$15
Jan-03-24	Initiated	Barclays	Equal Weight	$15
Feb-02-23	Resumed	B. Riley Securities	Buy	$30
Nov-01-22	Initiated	Stifel	Buy	$19
Jul-15-22	Initiated	SVB Leerink	Outperform	$38
Oct-18-21	Resumed	B. Riley Securities	Buy	$102
Apr-13-21	Initiated	RBC Capital Mkts	Outperform	$65
Jan-03-19	Initiated	William Blair	Outperform

Show Previous Ratings

Oct-02-25 12:00PM	OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy? (Zacks) -7.27%
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-10-25 07:30AM	OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference (GlobeNewswire)
Sep-09-25 04:05PM	OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising (GlobeNewswire)
Sep-05-25 09:23AM	Best Growth Stocks to Buy for September 5th (Zacks)
07:54AM	Loading…
Sep-03-25 07:54AM	Best Growth Stocks to Buy for September 3rd (Zacks)
Sep-01-25 12:00PM	What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? (Zacks)
Aug-28-25 04:49PM	Stock Market Today: Nasdaq Up, S&P 500 Etches Record High As Lumentum Soars; Nvidia Ends Well Off Lows (Live Coverage) (Investor's Business Daily)
Aug-21-25 12:00PM	All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy (Zacks)
10:00AM	Best Momentum Stock to Buy for August 21st (Zacks)
Aug-19-25 07:30AM	OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth (GlobeNewswire) -6.95%
Aug-07-25 05:55PM	OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +34.74%
04:01PM	OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance (GlobeNewswire)
12:14PM	Shopify Q2 Earnings Beat Estimates, Revenues Jump Y/Y, Shares Rise (Zacks)
11:45AM	MKSI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Rise (Zacks)
09:52AM	Loading…
09:52AM	Fastly Posts Narrower Loss in Q2 Earnings, Revenues Rise Y/Y (Zacks)
09:19AM	Best Growth Stocks to Buy for August 7th (Zacks)
Aug-06-25 06:30PM	Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
12:42PM	AMD Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Fall (Zacks)
Aug-05-25 09:06AM	Best Growth Stocks to Buy for August 5th (Zacks)
Aug-01-25 05:02AM	Best Growth Stocks to Buy for August 1st (Zacks)
Jul-31-25 02:56PM	Bull Of The Day: OptimizeRX (OPRX) (Zacks)
08:39AM	Does OptimizeRx Have a Moat in the Crowded HealthTech Space? (Zacks)
Jul-30-25 08:25AM	Blackbaud (BLKB) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Jul-28-25 08:41AM	Take the Zacks Approach to Beat the Markets: AngloGold Ashanti, Caterpillar & Hershey in Focus (Zacks)
Jul-25-25 08:41AM	OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum? (Zacks)
Jul-22-25 09:21AM	Best Growth Stocks to Buy for July 22nd (Zacks)
Jul-18-25 08:34AM	Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? (Zacks) -7.29%
Jul-17-25 07:30AM	OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET (GlobeNewswire)
Jul-16-25 09:30AM	OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? (Zacks) +9.25%
08:22AM	Loading…
08:22AM	Synopsys (SNPS) Moves 3.6% Higher: Will This Strength Last? (Zacks)
Jul-12-25 07:30AM	'Story' stocks are smoking hot in 2025. This is how it could end badly for investors. (MarketWatch)
Jul-11-25 08:01AM	OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? (Zacks)
Jul-09-25 08:24AM	Best Growth Stocks to Buy for July 9th (Zacks)
Jul-04-25 09:49AM	Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? (Zacks)
Jul-03-25 10:33AM	OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? (Zacks)
Jun-25-25 07:41AM	Best Growth Stocks to Buy for June 25th (Zacks)
Jun-24-25 07:30AM	OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors (GlobeNewswire)
Jun-20-25 10:13AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
Jun-18-25 03:00AM	Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions (Business Wire)
Jun-06-25 12:00PM	Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy (Zacks)
Jun-04-25 05:52AM	New Strong Buy Stocks for June 4th (Zacks)
May-23-25 10:54AM	DSGX's Solution Used by ArrowXL to Boost Last Mile Delivery (Zacks)
May-22-25 12:20PM	Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain? (Zacks)
May-16-25 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.32%
May-13-25 08:08AM	Q1 2025 OptimizeRx Corp Earnings Call (Thomson Reuters StreetEvents) +19.67%
03:08AM	OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts (GuruFocus.com)
May-12-25 05:35PM	OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates (Zacks) -7.91%
04:05PM	OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance (GlobeNewswire)
May-09-25 09:43AM	Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q1 2025 Result (GuruFocus.com)
May-01-25 04:05PM	OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report (GlobeNewswire) +5.70%
Apr-30-25 05:15PM	Microsoft (MSFT) Q3 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 05:15PM	Cadence Design Systems (CDNS) Beats Q1 Earnings and Revenue Estimates (Zacks) +5.03%
Apr-23-25 07:30AM	OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET (GlobeNewswire)
Apr-18-25 04:15PM	OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment (GlobeNewswire)
Mar-17-25 08:31AM	Why OptimizeRx Corp. (OPRX) Soared Last Week? (Insider Monkey) +6.44%
Mar-13-25 03:03AM	OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion (GuruFocus.com) +13.85%
01:25AM	Q4 2024 OptimizeRx Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-12-25 08:45AM	OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates (Zacks) +51.69%
07:30AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-11-25 07:30AM	OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations (GlobeNewswire)
Mar-10-25 07:30AM	OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer (GlobeNewswire) -6.11%
Feb-27-25 07:30AM	OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET (GlobeNewswire)
Feb-05-25 01:36PM	Whetstone Capital Discloses 8.2% Stake in OptimizeRx, Urges Strategic Alternatives (GuruFocus.com)
Jan-08-25 08:37AM	OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook (Investing.com) -7.04%
Dec-25-24 09:05AM	OptimizeRx price target lowered to $13 from $17 at B. Riley (TipRanks)
08:40AM	Lake Street reiterates Buy on OptimizeRx after surprising CEO departure (TipRanks)
Dec-23-24 08:45AM	OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO (GlobeNewswire)
Nov-18-24 07:30AM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire) +9.80%
Nov-14-24 02:15AM	OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ... (GuruFocus.com) -33.98%
Nov-13-24 05:35PM	OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates (Zacks) +5.31%
04:05PM	OptimizeRx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 09:12AM	OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? (Zacks)
Oct-31-24 07:30AM	OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET (GlobeNewswire)
Oct-03-24 04:25AM	OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? (Zacks)
Sep-10-24 07:30AM	OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value (GlobeNewswire)
Sep-09-24 12:00PM	OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences (GlobeNewswire)
Sep-04-24 09:35AM	Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 06:25PM	OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates (Zacks) +6.88% -5.31%
04:05PM	OptimizeRx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 10:01AM	OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-24 07:30AM	OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET (GlobeNewswire)
Jul-23-24 07:30AM	OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation (GlobeNewswire)
Jul-15-24 07:30AM	OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients (GlobeNewswire)
Jun-20-24 07:30AM	New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations (GlobeNewswire)
May-14-24 08:56PM	OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +25.67%
04:01PM	OptimizeRx Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 09:55AM	Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect? (Zacks)
May-06-24 04:30PM	OptimizeRx to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-26-24 07:30AM	OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET (GlobeNewswire) +15.00%
Apr-23-24 09:35AM	After Plunging -22.84% in 4 Weeks, Here's Why the Trend Might Reverse for OptimizeRx (OPRX) (Zacks)
Apr-22-24 09:35AM	Down -18.75% in 4 Weeks, Here's Why You Should You Buy the Dip in OptimizeRx (OPRX) (Zacks)
Apr-18-24 07:30AM	OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report (GlobeNewswire)
Apr-16-24 07:00AM	OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Apr-11-24 07:30AM	OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row (GlobeNewswire)
Apr-06-24 06:00AM	7 Top Undervalued Stocks Primed for a Multibagger Recovery (InvestorPlace)
Apr-01-24 03:02PM	OptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.01%
Mar-28-24 09:54PM	OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 07:30AM	OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET (GlobeNewswire)
Mar-11-24 04:30PM	OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 (GlobeNewswire) -14.12%

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Odence-Ford Marion	Chief Legal & Admin Officer	Oct 03 '25	Option Exercise	0.00	6,649	0	92,550	Oct 07 06:46 PM
Silvestro Stephen L	Chief Executive Officer	Oct 03 '25	Option Exercise	0.00	6,649	0	190,536	Oct 07 06:26 PM
Silvestro Stephen L	Chief Executive Officer	Oct 03 '25	Sale	18.75	1,620	30,375	188,916	Oct 07 06:26 PM
Stelmakh Edward	Chief Finance & Strat Officer	Oct 03 '25	Option Exercise	0.00	16,623	0	127,387	Oct 07 06:25 PM
Besch Doug	Chief Product & Tech Officer	Oct 03 '25	Option Exercise	0.00	3,325	0	70,555	Oct 07 05:52 PM
Spangler Patrick D	Director	Aug 28 '25	Sale	17.49	11,120	194,489	44,215	Sep 11 01:55 PM
Spangler Patrick D	Director	Aug 28 '25	Proposed Sale	17.81	11,120	198,000		Aug 29 02:31 PM
Lang James Paul	Director	Mar 14 '25	Buy	7.60	321,408	2,443,761	389,452	Mar 19 07:40 PM
Silvestro Stephen L	Chief Commercial Officer	Mar 01 '25	Option Exercise	0.00	1,928	0	121,886	Mar 04 09:18 AM
Odence-Ford Marion	Chief Legal Officer & CHRO	Mar 01 '25	Option Exercise	0.00	771	0	70,544	Mar 04 09:16 AM
KLEMA CATHY	Director	Feb 02 '25	Option Exercise	0.00	5,109	0	11,752	Feb 04 06:50 PM
Odence-Ford Marion	General Counsel and CCO	Dec 19 '24	Option Exercise	0.00	3,927	0	28,383	Dec 20 07:48 PM
Silvestro Stephen L	Chief Commercial Officer	Dec 19 '24	Option Exercise	0.00	6,546	0	83,424	Dec 20 07:47 PM
Besch Doug	Chief Product Officer	Dec 19 '24	Option Exercise	0.00	1,964	0	12,160	Dec 20 07:47 PM
Stelmakh Edward	CFO/COO	Dec 19 '24	Option Exercise	0.00	5,237	0	38,603	Dec 20 07:46 PM
FEBBO WILLIAM J	CEO	Dec 12 '24	Buy	5.01	20,000	100,220	601,253	Dec 16 02:28 PM
Odence-Ford Marion	General Counsel and CCO	Nov 08 '24	Option Exercise	0.00	1,785	0	24,980	Nov 12 09:37 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OPRX

OptimizeRx Corp

Upgrade your FINVIZ experience